☆ 4.8 Article

A Traceless Vascular-Targeting Antibody-Drug Conjugate for Cancer Therapy

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)

Get Full Text
Add to Collection

Journal

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 51, Issue 4, Pages 941-944

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.201106527

Keywords

angiogenesis; antibody-drug conjugates; cancer; cemadotin; drug delivery

Categories

Chemistry, Multidisciplinary

Funding

  1. ETH Zurich
  2. Swiss National Science Foundation
  3. Swiss-Bridge/Stammbach Stiftung
  4. Kommission fur Technologie und Innovation (KTI)
  5. Philochem AG

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.